Dr. Krishnendu (Krish) Roy is currently the Robert A. Milton Chaired Professor of Biomedical Engineering at Georgia Tech, where he also serves as the director of the newly established NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT) and The Marcus Center for Cell–Therapy Characterization and Manufacturing (MC3M) – as well as the director of the Center for Immunoengineering. CMaT and MC3M are dedicated to develop new engineering tools and technologies to transform the manufacture of cell–based therapeutics into a large–scale, low–cost, reproducible, and high–quality engineered system for broad industry and clinical use. These centers are visionary and strategic international resources and exemplars for developing new knowledge, transformative technologies, an inclusive well–trained workforce and enabling standards for cell–production and characterization processes. Dr. Roy is also the technical lead of the NIST/AMTech National Cell Manufacturing Consortium (NCMC), a national public–private partnership, focused on addressing the challenges and solutions for large–scale manufacturing of cell therapies. Dr. Roy’s research interests are in the areas of scalable cell manufacturing, immunoengineering, stem cell engineering and controlled drug and vaccine delivery technologies, with particular focus in biomedical materials. Dr. Roy is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE) and fellow of the Biomedical Engineering Society (BMES), a member of the Forum on Regenerative Medicine of the National Academies of Science, Engineering and Medicine (NASEM) and a board member of the newly established Standards Coordinating Body (SCB) for Cell and Regenerative Therapies. He also serves on the editorial board of several journals.